Seminars in Diagnostic Pathology
Volume 26, Issue 2 , Pages 77-88 , May 2009

Vasculitides of the gastrointestinal tract

  • Eric Ahn, MD

      Affiliations

    • Department of Pathology, Toronto General Hospital/University Health Network, Toronto, ON, Canada
    • ,
  • Adriana Luk, MD

      Affiliations

    • Departments of Medicine and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
    • ,
  • Runjan Chetty, MB, ChB, FRCPath, FRCPC, DPhil

      Affiliations

    • Department of Pathology, Toronto General Hospital/University Health Network, Toronto, ON, Canada
    • ,
  • Jagdish Butany, MBBS, MS, FRCPC

      Affiliations

    • Department of Pathology, Toronto General Hospital/University Health Network, Toronto, ON, Canada
    • Corresponding Author InformationAddress reprint requests and correspondence: Jagdish Butany, MBBS, MS, FRCPC, Department of Pathology, 11th Floor, Toronto General Hospital, 200 Elizabeth St, Toronto, ON, Canada M5G 2C4

References 

  1. Hahn BH. Systemic lupus erythematosus. In:  Kasper DL,  Braunwald E,  Fauci AS, et al. editor. Harrison's Principles of Internal Medicine. Toronto: McGraw-Hill Medical Publishing Division; 2005;p. 1960–1967
  2. Grimbacher B, Huber M, von Kempis J, et al. Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: A clinical case report and review of the literature. Br J Rheumatol. 1998;37:1023–1028
  3. Drenkard C, Villa AR, Reyes E, et al. Vasculitis in systemic lupus erythematosus. Lupus. 1997;6:235–242
  4. Medina F, Ayala A, Jara LJ, et al. Acute abdomen in systemic lupus erythematosus: The importance of early laparotomy. Am J Med. 1997;103:100–105
  5. Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatol Oxf. 2000;39:1147–1152
  6. Tsushima Y, Uozumi Y, Yano S. Reversible thickening of the bowel and urinary bladder wall in systemic lupus erythematosus: A case report. Radiat Med. 1996;14:95–97
  7. Ko SF, Lee TY, Cheng TT, et al. CT findings at lupus mesenteric vasculitis. Acta Radiol. 1997;38:115–120
  8. Laing TJ. Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: Successful treatment with pulse intravenous cyclophosphamide. Am J Med. 1998;85:555–558
  9. Eberhard A, Shore A, Silverman E, Laxer R. Bowel perforation and interstitial cystitis in childhood systemic lupus erythematosus. J Rheumatol. 1991;18:746–747
  10. Turner HE, Myszor MF, Bradlow A, David J. Lupus or lupoid hepatitis with mesenteric vasculitis. Br J Rheumatol. 1996;35:1309–1311
  11. Kistin MG, Kaplan MM, Harrington JT. Diffuse ischemic colitis associated with systemic lupus erythematosus: Response to subtotal colectomy. Gastroenterology. 1978;75:1147–1151
  12. Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease: An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148–159
  13. Prokop J, Jagodzinski PP. Identification of retroviral conserved pol sequences in serum of mixed connective tissue disease and systemic sclerosis patients. Biomed Pharmacother. 2004;58:61–64
  14. Greidinger EL, Foecking MF, Magee J, et al. A major B cell epitope present on the apoptotic but not the intact form of the U1-70-kDa ribonucleoprotein autoantigen. J Immunol. 2004;172:709–716
  15. Kasukawa R. Mixed connective tissue disease. Intern Med. 1999;38:386–393
  16. Bennett RM, O'Connell DJ. The arthritis of mixed connective tissue disease. Ann Rheum Dis. 1978;37:397–403
  17. Halla JT, Hardin JG. Clinical features of the arthritis of mixed connective tissue disease. Arthritis Rheum. 1978;21:497–503
  18. Bennett RM, Spargo BH. Immune complex nephropathy in mixed connective tissue disease. Am J Med. 1977;63:534–541
  19. Kitridou RC, Akmal M, Turkel SB, et al. Renal involvement in mixed connective tissue disease: A longitudinal clinicopathologic study. Semin Arthritis Rheum. 1986;16:135–145
  20. Farhey Y, Hess EV. Mixed connective tissue disease. Arthritis Care Res. 1997;10:333–342
  21. Venables PJW. Mixed connective tissue disease. Lupus. 2006;15:132–137
  22. Gilliland BC. Systemic sclerosis (scleroderma) and related disorders. In:  Kasper DL,  Braunwald E,  Fauci AS, et al. editor. Harrison's Principles of Internal Medicine. Toronto: McGraw-Hill Medical Publishing Division; 2005;p. 1979–1990
  23. Rasmussen EK, Ullman S, Hoier-Madsen M, et al. Clinical implications of ribonucleoprotein antibody. Arch Dermatol. 1987;123:601–605
  24. Marshall JB, Kretschmar JM, Gerhardt DC, et al. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology. 1990;98:1232–1238
  25. Lynn JT, Gossen G, Miller A, Russell IJ. Pneumatosis intestinalis in mixed connective tissue disease: Two case reports and literature review. Arthritis Rheum. 1984;27:1186–1189
  26. Rolny P, Goobar J, Zettergren L. HBsAg-negative chronic active hepatitis and mixed connective tissue disease syndrome (An unusual association observed in two patients). Acta Med Scand. 1984;215:391–395
  27. Tomsic M, Ferlan-Marolt V, Kveder T, et al. Mixed connective tissue disease associated with autoimmune hepatitis and thyroiditis. Ann Rheum Dis. 1992;51:544–546
  28. Fernandes C, Bungay P, O'Driscoll BR, Herrick AL. Mixed connective tissue disease presenting with pneumonitis and pneumatosis intestinalis. Arthritis Rheum. 2000;43:704–707
  29. Hameenkorpi R, Ruuska P, Forsberg S, et al. More evidence of distinctive features of mixed connective tissue disease. Scand J Rheumatol. 1993;22:63–68
  30. Alarcon-Segovia D. Mixed connective tissue disease and overlap syndromes. Clin Dermatol. 1994;12:309–316
  31. Amigues JM, Cantagrel A, Abbal M, Mazieres B. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies (Autoimmunity Group of the Hospitals of Toulouse). J Rheumatol. 1996;23:2055–2062
  32. Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease (Study of 593 patients). J Rheumatol. 1989;16:328–334
  33. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol. 1998;93:1085–1089
  34. ter Borg EJ, Houtman PM, Kallenberg CG, et al. Thrombocytopenia and hemolytic anemia in a patient with mixed connective tissue disease due to thrombotic thrombocytopenic purpura. J Rheumatol. 1988;15:1174–1177
  35. Dahl M, Chalmers A, Wade J, et al. Ten-year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy. J Rheumatol. 1992;19:1807–1809
  36. Alpert MA, Pressly TA, Mukerji V, et al. Short- and long-term haemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease. Chest. 1992;102:1407–1412
  37. Ueda Y, Yamauchi Y, Makizumi K, et al. Successful treatment of acute right cardiac failure due to pulmonary thromboembolism in mixed connective tissue disease. Jpn J Med. 1991;30:568–572
  38. Alpert MA, Pressly TA, Mukerji V, et al. Acute and long-term effects of nifedipine on pulmonary and systemic haemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. Am J Cardiol. 1991;68:1687–1691
  39. McLaughlin VV, Genthner DE, Panella MM, et al. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: A case series. Ann Intern Med. 1999;130:740–743
  40. Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum. 1994;37:1265–1282
  41. Suzuki M, Hamada M, Sekiya M, et al. Fatal pulmonary hypertension in a patient with mixed connective tissue disease: Report of an autopsy case. Intern Med. 1992;31:74–77
  42. Jones MB, Osterholm RK, Wilson RB, et al. Fatal pulmonary hypertension and resolving immune-complex glomerulonephritis in mixed connective tissue disease (A case report and review of the literature). Am J Med. 1978;65:855–863
  43. Burdt MA, Hoffman RW, Deutscher SL, et al. Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899–909
  44. Esaki M, Matsumoto T, Nakamura S, et al. GI involvement in Henoch-Schonlein purpura. Gastrointest Endosc. 2002;56:920–923
  45. Agha FP, Nostrant TT, Keren DF. Leukocytoclastic vasculitis (hypersensitivity angiitis) of the small bowel presenting with severe gastrointestinal hemorrhage. Am J Gastroenterol. 1986;81:195–198
  46. Tizard EJ. Henoch Schonlein purpura. Arch Dis Child. 1999;80:380–383
  47. Roberts PF, Waller TA, Brinker TM, et al. Henoch Schonlein purpura: A review article. South Med J. 2007;100:821–824
  48. Pore G. GI lesions in Henoch-Schonlein purpura. Gastrointest Endosc. 2002;55:283–286
  49. Lanzkowsky S, Lanskowsky L, Lanzkowsky P. Henoch-Schonlein purpura. Pediatr Rev. 1992;13:130–137
  50. Chen MJ, Wang TE, Chang WH, et al. Endoscopic findings in a patient with Henoch Schonlein purpura. World J Gastroenterol. 2005;11:2356
  51. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, et al. Henoch-Schonlein purpura in adulthood and childhood: Two different expressions of the same syndrome. Arthritis Rheum. 1998;41:1518–1520
  52. Connolly B, O'Halpin D. Sonographic evaluation of the abdomen in Henoch-Schonlein purpura. Clin Radiol. 1994;49:320–323
  53. Jeong YK, Ha HK, Yoon CH, et al. Gastrointestinal involvement in Henoch Schonlein syndrome: CT finding. Am J Roentgenol. 1997;168:965–968
  54. Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 Criteria for the classification of Henoch Schonlein Purpura. Arthritis Rheum. 1990;233:1114–1121
  55. Lawes D, Wood J. Acute abdomen in Henoch-Schonlein purpura. J R Soc Med. 2002;95:505–506
  56. Weiss PF, Feinstein X, Luan JA, et al. Effects of corticosteroid on Henoch Schonlein purpura: A systematic review. Pediatrics. 2007;120:1079–1087
  57. Pillebout E, Thervet E, Hill G, et al. Henoch Schonlein purpura in adults: Outcome and prognostic factors. J Am Soc Nephrol. 2002;13:1271–1278
  58. Saulsbury FT. Henoch Schonlein purpura. Curr Opin Rheumatol. 2001;13:35–40
  59. Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyagiitis and Churg-Strauss syndrome. Lupus. 1998;7:238–258
  60. de Carpi JM, Castejon E, Masiques L, et al. Gastrointestinal involvement in pediatric polyarteritis nodosa. J Pediatr Gastroenterol Nutr. 2007;44:274–278
  61. Adajar MA, Painter T, Woloson S, Memark V. Isolated celiac artery aneurysm with splenic artery stenosis as a rare presentation of polyarteritis nodosum: A case report and review of the literature. J Vasc Surg. 2006;44:647–650
  62. Levine SM, Hellmann DB, Stone JH. Gastrointestinal involvement in polyarteritis nodosa, 1986-2000: Presentation and outcomes in 24 patients. Am J Med. 2002;112:386–391
  63. Zizec TM, Classen JN, Stevens MB. Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am J Med. 1982;73:525–531
  64. Hekali P, Kajander H, Pajari R, et al. Diagnostic significance of angiographically obsered visceral aneurysms with regard to polyarteritis nodosa. Acta Radiol. 1991;32:143–148
  65. Hagspiel KD, Angle JF, Spinosa DJ, Matsumoto AH. Case 13: Polyarteritis nodosa-systemic necrotizing vasculitis with involvement of hepatic and superior mesenteric arteries. Radiology. 1999;212:359–364
  66. Lightfoot RW, Michel BA, Bloch DA, et al. The American College of Rheumatology criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088–1093
  67. Seo P. Polyarteritis nodosa: The great mimicker, mimicked. South Med J. 2008;101:351–352
  68. Gayraud M, Guillevin L, le Toumelin P, et al. Long-term follow up of polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Arthritis Rheum. 2001;44:666–675
  69. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome (A prospective study in 342 patients). Med Baltimore. 1996;75:17–28
  70. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet. 2003;361:587–594
  71. Sneller MC, Langford CA, Fauci AS. The vasculitis syndrome. In:  Kasper DL,  Braunwald E,  Fauci AS, et al. editor. Harrison's Principles of Internal Medicine. Toronto: McGraw-Hill Medical Publishing Division; 2005;p. 2002–2014
  72. Churg A. Pulmonary angiitis and granulomatosis revisited. Hum Pathol. 1983;14:868–883
  73. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: A clinical approach to the Churg-Strauss syndrome. Med Baltimore. 1984;63:65–81
  74. Kim YB, Choi SW, Park IS, et al. Churg-Strauss syndrome with perforating ulcers of the colon. J Korean Med Sci. 2000;15:585–588
  75. Mir O, Nazal EM, Cohen P, et al. Esophageal involvement as an initial manifestation of Churg-Strauss syndrome. Presse Med. 2007;36:57–60
  76. Nishie M, Kamijo TM, Kannari M, et al. Acute cholecystitis and duodenitis associated with Churg-Strauss syndrome. Hepatogastroenterology. 2003;50:998–1002
  77. Suzuki M, Nabeshima K, Mitsukazu M, et al. Churg-Strauss syndrome complicated by colon erosion, acalculous cholecystitis and liver abscesses. World J Gastroenterol. 2005;11:5248–5250
  78. Kaneki T, Kawashima A, Hayano T, et al. Churg-Strauss syndrome (allergic granulomatous angitis) presenting with ileus caused by ischemic ileal ulcer. J Gastroenterol. 1998;33:112–116
  79. Hayashi K, Horie Y, Takahata H, et al. Ileal ulcers and cytomegalovirus infection in a case of Churg-Strauss syndrome. Arch Pathol Lab Med. 2005;129:e141–e143
  80. Memain N, De Bandt M, Guillevin L, et al. Delayed relapse of Churg-Strauss syndrome manifesting as colon ulcers with mucosal granulomas: 3 cases. J Rheumatol. 2002;29:388–391
  81. Lin TL, Wang CR, Liu MF, et al. Multiple colonic ulcers caused by Churg-Strauss syndrome in a 15-year-old girl. Clin Rheumatol. 2001;20:362–364
  82. Kurita M, Niwa Y, Hamada E, et al. Churg-Strauss syndrome (allergic granulomatous antiitis) with multiple perforating ulcers of the small intestine, multiple ulcers of the colon, and mononeuritis multiplex. J Gastroenterol. 1994;29:208–213
  83. Sharma MC, Sidhu SR. Perforation of small intestine caused by Churg-Strauss syndrome. J Clin Gastroenterol. 1996;23:232–235
  84. Murakami S, Misumi M, Sakata H, et al. Syndrome manifesting as perforation of the small intestine: Report of a case. Surg Today. 2004;34:788–792
  85. Keogh KA, Specks U. Churg-Strauss syndrome (Clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists). Am J Med. 2003;115:284–290
  86. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094–1100
  87. Katzenstein AL. Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung (A review). Am J Clin Pathol. 2000;114:767–772
  88. Asurikisawa N, Taniguchi M, Saito H, et al. Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. Ann Allerg Asthma Immunol. 2004;92:80
  89. Hellmich B, Gross WL. Recent progress in the pharmacotherapy of Churg-Strauss syndrome. Expert Opin Pharmacother. 2004;5:25–35
  90. Guillevin L, Cohen P, Gayraud M, et al. Clinical study and long-term follow-up of 96 patients. Medicine. 1999;78:26
  91. Warshaw AL, Welch JP, Ottinger LW. Acute perforation of the colon associated with chronic corticosteroid therapy. Am J Surg. 1976;131:442–446
  92. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med. 1992;116:488–499
  93. Deger SM, Sahin T, Vural C, et al. Wegener's granulomatosis with massive gastrointestinal hemorrhage due to jejunal and colonic involvement: Report of a case. Surg Today. 2008;38:166–169
  94. Fauci AS, Katz HBF, Wolff P, Smi WG. Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76–85
  95. Steele C, Bohra S, Broe P, Murray FE. Acute upper gastrointestinal haemorrhage and colitis: An unusual presentation of Wegener's granulomatosis. Eur J Gastroenterol Hepatol. 2001;13:993–995
  96. Spiera RG, Bains FDA, Paget SA. Esophageal involvement in Wegener's granulomatosis. Arthritis Rheum. 1994;37:1404–1407
  97. Storesund B, Gran JT, Koldingsnes W. Severe intestinal involvement in WG: Report of two cases and review of the literature. Br J Rheum. 1998;37:387–390
  98. Akca T, Colak T, Caglikulekci M, et al. Intestinal perforation in Wegener's granulomatosis: A case report. Turk J Trauma Emerg Surg. 2005;11:348–351
  99. Geraghty J, Mackay IR, Smith DC. Intestinal perforation in Wegener's granulomatosis. Gut. 1986;27:450–451
  100. Gal AA, Masor JJ. Splenic involvement in Wegener's granulomatosis. Arch Pathol Lab Med. 1996;120:974–977
  101. Tinazzi I, Caramaschi P, Parisi A, et al. Pancreatic granulmatous necrotizing vasculitis: A case report and review of the literature. Rheumatol Int. 2007;27:989–991
  102. Finkielman JD, Lee AS, Hummel AM, et al. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med. 2007;120:643e9-643e14
  103. Kallenberg CG, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int. 1994;46:1–15
  104. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum. 1998;41:1521–1537
  105. Travis WD, Hoffman GS, Leavitt RY, et al. Surgical pathology of the lung in Wegener's granulomatosis (Review of 87 open lung biopsies from 67 patients). Am J Surg Pathol. 1991;15:315–333
  106. Nachman PH, Hogan SL, Jennette JC, et al. Treatment response and relapse in antineutrophil cytoplasmic antibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7:33–39
  107. De Groot K, Rasmussen N, Bacon PA, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52:2461–2469
  108. Klemmer PJ, Chalermskulrat W, Reif M, et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis. 2003;42:1149–1153
  109. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis. Arthritis Rheum. 1999;42:421–430
  110. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–192
  111. Savage CO, Winearls CG, Evans DJ, et al. Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med. 1985;56:467–483
  112. Spahn TW, Ullerich HJ, Letitz P, et al. Gastrointestinal bleeding secondary to hepatic artery involvemetn of microscopic polyangiitis: Case report and review of the literature. Digest Dis Sci. 2007;52:1558–1561
  113. Ueda S, Matsumoto M, Ahn Tatsuichi AS, et al. Microscopic polyangiitis complicated with massive intestinal bleeding. J Gastroenterol. 2001;36:264–270
  114. Komanduri S, Jakate S, Keshavarzian A. Focal rectal capillaritis: Microscopic polyangiitis presenting as painless rectal bleeding. J Clin Gastroenterol. 2002;35:157–159
  115. Nakamoto T, Yoshikawa T, Yamane Y, et al. Microscopic polyangiitis that presented liver dysfunction prior to noted renal manifestations. Intern Med. 2000;39:517–521
  116. Takebayashi K, Aso Y, Kitamura H, et al. Microscopic polyangiitis presenting with liver dysfunction preceding rapidly progressive necrotizing glomerulonephritis. South Med J. 2004;97:911–914
  117. Matsumoto M, Nakamura T, Ohashi T, et al. Esophageal involvement in microscopic polyangiitis: A case report and review of literature. Intern Med. 2007;46:663–667
  118. Haraguchi K, Gunji K, Ito Y, et al. Extensive pancreatic necrosis in microscopic polyangiitis. Clin Exp Nephrol. 2005;9:326–331
  119. Tsai CN, Chang CM, Chuang CH, et al. Extended colonic ulcerations in a patient with microscopic polyangiitis. Ann Rheum Dis. 2004;63:1521–1522
  120. Amezcua-Guerra LM, Prieto P, Bojalil R, et al. Microscopic polyangiitis associated with primary biliary cirrhosis: A causal or casual association?. J Rheumatol. 2006;33:2351–2353
  121. Iannone F, Falappone P, Pannarale G, et al. Microscopic polyangiitis associated with primary ciliary cirrhosis. J Rheumatol. 2003;30:2710–2712
  122. Bjornsson J. Histopathology of primary vasculitic disorders. In:  Hoffman GS,  Weyand CM editor. Inflammatory Diseases of Blood Vessels. New York: Marcel Dekker; 2002;p. 261–262
  123. Saraga E, Costa J. Idiopathic enterocolic lymphocytic phlebitis (A cause of intestinal ischemic necrosis). Am J Surg Pathol. 1989;13:303–308
  124. Ngo N, Chang F. Enterocolic lymphocytic phlebitis: Clinicopathologic features and review of literature. Arch Pathol Lab Med. 2007;131:1130–1134
  125. Wright CL, Cacala S. Enterocolic lymphocytic phlebitis with lymphocytic colitis, lymphocytic appendicitis, and lymphocytic enteritis. Am J Surg Pathol. 2004;28:542–547
  126. Arora DS, Mahmood T, Wyatt JI. Lymphocytic venulitis: An unusual association with microscopic colitis. J Clin Pathol. 1999;52:303–304
  127. Jain R, Chetty R. Enterocolic lymphocytic phlebitis and lymphocytic colitis: Drug-related coexistent pathology. Int J Colorectal Dis. 2009;24:473–474
  128. Chetty R, Hafezi S, Montgomery E. An incidental enterocolic lymphocytic phlebitis pattern is seen commonly in the rectal stump of patients with diversion colitis superimposed on inflammatory bowel disease. J Clin Pathol. 2009;62:464–467
  129. Ebert EC. Gastrointestinal manifestations of Behcet's disease. Digest Dis Sci. 2009;54:201–207
  130. Bayraktar Y, Balkanci F, Kansu E, et al. Budd–Chiari syndrome: Analysis of 30 cases. Angiology. 1993;44:541–551
  131. Slavin RE, Gonzalez-Vitale JC. Segmental mediolytic arteritis: A clinical pathological study. Lab Invest. 1976;35:23–29
  132. Inada K, Maeda M, Ikeda T. Segmental arterial mediolysis: Unrecognized cases culled from cases of ruptured aneurysm of abdominal visceral arteries reported in the literature. Pathol Res Pract. 2007;203:771–778
  133. Chan RJ, Goodman TA, Aretz TH, Lie JT. Segmental mediolytic arteriopathy of the splenic and hepatic arteries mimicking systemic necrotizing vasculitis. Arthritis Rheum. 1998;41:935–938
  134. Lie JT. Systemic, cerebral, and pulmonary segmental Mediolytic arteriopathy: Villainous masqueraders of vasculitis. Cardiovasc Pathol. 1996;5:305–314

PII: S0740-2570(09)00016-1

doi: 10.1053/j.semdp.2009.06.001

Seminars in Diagnostic Pathology
Volume 26, Issue 2 , Pages 77-88 , May 2009

Article Tools

* Image Usage & Resolution